StockData
Teladoc Health, Inc. logo

Teladoc Health, Inc. (TDOC) stock

TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.49−0.21 (-2.41%)

Close on Nov 17, 2026Market cap $1.55BP/E –Yield –

Teladoc Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Teladoc Health's price to sales ratio was 0.7× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.4× to 7.9×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.2
2025Dec 31, 20250.5×−0.1
2024Dec 31, 20240.6×−0.8
2023Dec 29, 20231.4×−0.3
2022Dec 30, 20221.7×−6.2
2021Dec 31, 20217.9×−11.6
2020Dec 31, 202019.5×+7.8
2019Dec 31, 201911.7×+2.3
2018Dec 31, 20189.3×−0.9
2017Dec 29, 201710.2×+3.2
2016Dec 30, 20167.0×−3.2
2015Dec 31, 201510.2×–

More Teladoc Health figures

See a number that looks wrong?